Company: RGBP
Filing Date: 2025-09-08
Form Type: 253G1
Source: 0001641172-25-026822
Chunk: 103

Company: Regen BioPharma Inc
Filing Date: 2025-09-08
Form: 253G1
Chunk 103
---
 by David Koos, the Company’s sole Board Member and Officer, is due and payable at the demand of the holder and bears simple interest at a rate of 15% per annum.

$15,000 lent to the Company by Zander Therapeutics, Inc. is due and payable on May 3. 2025 and bears simple interest at a rate of 10% per annum.

$25,000 lent to the Company by Zander Therapeutics, Inc. is due and payable on June 5. 2025 and bears simple interest at a rate of 10% per annum.

$10,000 lent to the Company by Zander Therapeutics, Inc. is due and payable on October 4, 2025 and bears simple interest at a rate of 10% per annum.

$4,700 lent to the Company by Zander Therapeutics, Inc. is due and payable on October 15 2025 and bears simple interest at a rate of 10% per annum.

$4,500 lent to the Company by Zander Therapeutics, Inc. is due and payable on October 23 2025 and bears simple interest at a rate of 10% per annum.

Zander Therapeutics, Inc. and the Company are under common control.

During the quarter ended December 31, 2024 BST Partners lent the Company $46,599

During the quarter ended March 31, 2025 BST Partners lent the Company $40,616.

BST Partners and the Company are under common control.

| 83 |

<div align='center'>REGEN BIOPHARMA , INC.

CONDENSED CONSOLIDATED BALANCE SHEETS</div>

| ASSETS:                                                                                           
 Current Assets                                                                                    |     | December 31, 
 2024         
 (Unaudited)  |             |   |     | September 30, 
 2024          
 (As Restated) |             |   |
|:--------------------------------------------------------------------------------------------------|:----|:-------------|------------:|:--|:----|:--------------|------------:|:--|
| Cash                                                                                              |     | $            |         135 |   |     |               |         716 |   |
| Accounts receivable, related party                                                                |     |              |     122,298 |   |     |               |      94,873 |   |
| Prepaid expenses                                                                                  |     |              |      51,250 |   |     |               |      47,